Outlook Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-27.5M | $-36.3M | $8.8M | $11.2M |
| FY2016 | $-45.5M | $-46.6M | $1.1M | $12.5M |
| FY2017 | $-15.5M | $-15.8M | $292.1K | $8.6M |
| FY2018 | $-33.0M | $-35.8M | $2.8M | $2.0M |
| FY2019 | $-32.3M | $-32.7M | $437.3K | $1.3M |
| FY2020 | $-31.8M | $-31.8M | — | $2.8M |
| FY2021 | $-54.3M | $-54.3M | — | $4.9M |
| FY2022 | $-56.7M | $-56.7M | — | $7.7M |
| FY2023 | $-43.0M | $-43.0M | — | $5.5M |
| FY2024 | $-68.8M | $-68.8M | — | $5.4M |
| FY2025 | $-51.8M | $-51.8M | — | $8.9M |